<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37011198</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><Issue>15</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Neuronal activity regulates Matrin 3 abundance and function in a calcium-dependent manner through calpain-mediated cleavage and calmodulin binding.</ArticleTitle><Pagination><StartPage>e2206217120</StartPage><MedlinePgn>e2206217120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2206217120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2206217120</ELocationID><Abstract><AbstractText>RNA-binding protein (RBP) dysfunction is a fundamental hallmark of amyotrophic lateral sclerosis (ALS) and related neuromuscular disorders. Abnormal neuronal excitability is also a conserved feature in ALS patients and disease models, yet little is known about how activity-dependent processes regulate RBP levels and functions. Mutations in the gene encoding the RBP Matrin 3 (MATR3) cause familial disease, and MATR3 pathology has also been observed in sporadic ALS, suggesting a key role for MATR3 in disease pathogenesis. Here, we show that glutamatergic activity drives MATR3 degradation through an NMDA receptor-, Ca<sup>2+</sup>-, and calpain-dependent mechanism. The most common pathogenic <i>MATR3</i> mutation renders it resistant to calpain degradation, suggesting a link between activity-dependent MATR3 regulation and disease. We also demonstrate that Ca<sup>2+</sup> regulates MATR3 through a nondegradative process involving the binding of Ca<sup>2+</sup>/calmodulin to MATR3 and inhibition of its RNA-binding ability. These findings indicate that neuronal activity impacts both the abundance and function of MATR3, underscoring the effect of activity on RBPs and providing a foundation for further study of Ca<sup>2+</sup>-coupled regulation of RBPs implicated in ALS and related neurological diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Ahmed M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-2625-7483</Identifier><AffiliationInfo><Affiliation>Medical Scientist Training Program, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Josephine J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0001-8740-7716</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cellular and Molecular Biology Graduate Program, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillies</LastName><ForeName>Christie A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doctrove</LastName><ForeName>Quinlan A</ForeName><Initials>QA</Initials><Identifier Source="ORCID">0000-0002-6811-8828</Identifier><AffiliationInfo><Affiliation>Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Postbac Research Education Program, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xingli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Haoran</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Texas Southwestern Medical Center, Dallas, TX 75390.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tank</LastName><ForeName>Elizabeth H M</ForeName><Initials>EHM</Initials><Identifier Source="ORCID">0000-0002-1965-2012</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shakkottai</LastName><ForeName>Vikram G</ForeName><Initials>VG</Initials><Identifier Source="ORCID">0000-0003-2742-6469</Identifier><AffiliationInfo><Affiliation>University of Texas Southwestern Medical Center, Dallas, TX 75390.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barmada</LastName><ForeName>Sami</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9604-968X</Identifier><AffiliationInfo><Affiliation>Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cellular and Molecular Biology Graduate Program, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS097542</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 NS110119</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007863</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072931</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS113943</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007315</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002147">Calmodulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D002154">Calpain</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034521">Nuclear Matrix-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C518587">MATR3 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002147" MajorTopicYN="N">Calmodulin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002154" MajorTopicYN="N">Calpain</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034521" MajorTopicYN="N">Nuclear Matrix-Associated Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">NMDA</Keyword><Keyword MajorTopicYN="N">RNA binding protein</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37011198</ArticleId><ArticleId IdType="pmc">PMC10104577</ArticleId><ArticleId IdType="doi">10.1073/pnas.2206217120</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Purice M. D., Taylor J. P., Linking hnRNP function to ALS and FTD pathology. Front. Neurosci.-switz 12, 326 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5962818</ArticleId><ArticleId IdType="pubmed">29867335</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., et al. , TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602&#x2013;611 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., et al. , Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130&#x2013;133 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., et al. , TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572&#x2013;574 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., et al. , Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208&#x2013;1211 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T. J., et al. , Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205&#x2013;1208 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N., et al. , Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B, 285&#x2013;290 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21438137</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I. R., et al. , TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron 95, 808&#x2013;816.e9 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H. J., et al. , Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495, 467&#x2013;473 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Belgrader P., Dey R., Berezney R., Molecular cloning of Matrin 3. A 125-kilodalton protein of the nuclear matrix contains an extensive acidic domain. J. Biol. Chem. 266, 9893&#x2013;9899 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">2033075</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y., Nakamura K., Tsukada S., Sugano N., Purification and characterization of nuclear scaffold proteins which bind to a highly repetitive bent DNA from rat liver. Biochim. Biophys. Acta (BBA) - Gene Struct. Expression 1174, 162&#x2013;170 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8357833</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y., et al. , Molecular properties and intracellular localization of rat liver nuclear scaffold protein P130. Biochim. Biophys. Acta (BBA) - Gene Struct. Expression, 1759, 195&#x2013;207 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16814881</ArticleId></ArticleIdList></Reference><Reference><Citation>Senderek J., et al. , Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, Matrin 3. Am. J. Hum. Genet. 84, 511&#x2013;518 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2667977</ArticleId><ArticleId IdType="pubmed">19344878</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J. O., et al. , Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 17, 664&#x2013;666 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., et al. , Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients. Neurobiol. Aging 35, e13&#x2013;2882.e15 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25158920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K.-P., et al. , Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol. Aging 36, e1&#x2013;2005.e4 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25771394</ArticleId></ArticleIdList></Reference><Reference><Citation>Origone P., et al. , A novel Arg147Trp MATR3 missense mutation in a slowly progressive ALS Italian patient. Amyotroph. Lateral Scler. Frontotemporal Degener. 16, 530&#x2013;531 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26199109</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond C. S., et al. , Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 37, e17&#x2013;209.e21 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26493020</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Li J., Tang L., Zhang N., Fan D., MATR3 mutation analysis in a Chinese cohort with sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 38, e3&#x2013;218.e4 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26708275</ArticleId></ArticleIdList></Reference><Reference><Citation>Marangi G., et al. , Matrin 3 variants are frequent in Italian ALS patients. Neurobiol. Aging 49, e1&#x2013;218.e7 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28029397</ArticleId></ArticleIdList></Reference><Reference><Citation>Narain P., et al. , Identification and characterization of novel and rare susceptible variants in Indian amyotrophic lateral sclerosis patients. Neurogenetics 20, 197&#x2013;208 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31432357</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreser A., et al. , The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins. Cell Death Differ. 24,&#xa0;1655&#x2013;1671 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5596426</ArticleId><ArticleId IdType="pubmed">28622300</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada M., et al. , Matrin 3 is a component of neuronal cytoplasmic inclusions of motor neurons in sporadic amyotrophic lateral sclerosis. Am. J. Pathol. 188,&#xa0;507&#x2013;514 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29128563</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai K., et al. , Altered axonal excitability properties in amyotrophic lateral sclerosis: Impaired potassium channel function related to disease stage. Brain 129, 953&#x2013;962 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16467388</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S., Nicholson G. A., Kiernan M. C., Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 131, 1540&#x2013;1550 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18469020</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchand-Pauvert V., et al. , Absence of hyperexcitability of spinal motoneurons in patients with amyotrophic lateral sclerosis. J. Physiol. 597, 5445&#x2013;5467 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31523813</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikawa Y., et al. , Detecting motor unit abnormalities in amyotrophic lateral sclerosis using high-density surface EMG. Clin. Neurophysiol. 142, 262&#x2013;272 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35902304</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieri M., et al. , Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci. Lett. 351, 153&#x2013;156 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14623129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger B. J., et al. , Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 7, 1&#x2013;11 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin A.-C., et al. , Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat. Commun. 6, 339 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338554</ArticleId><ArticleId IdType="pubmed">25580746</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay E., Martineau &#xc9;., Robitaille R., Opposite Synaptic alterations at the neuromuscular junction in an ALS mouse model: When motor units matter. J. Neurosci. 37, 8901&#x2013;8918 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6596800</ArticleId><ArticleId IdType="pubmed">28821658</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Silva M., et al. , Hypoexcitability precedes denervation in the large fast-contracting motor units in two unrelated mouse models of ALS. Elife 7, e30955 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5922970</ArticleId><ArticleId IdType="pubmed">29580378</ArticleId></ArticleIdList></Reference><Reference><Citation>Amalyan S., et al. , Enhanced motor cortex output and disinhibition in asymptomatic female mice with C9orf72 genetic expansion. Cell Rep. 40, 111043 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35793625</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbasiouny S. M., Motoneuron excitability dysfunction in ALS: Pseudo-mystery or authentic conundrum? J. Physiol. 600, 4815&#x2013;4825 (2022), 10.1113/jp283630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jp283630</ArticleId><ArticleId IdType="pmc">PMC9669170</ArticleId><ArticleId IdType="pubmed">36178320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.-H., et al. , Calpain-2 mediates MBNL2 degradation and a developmental RNA processing program in neurodegeneration. J. Neurosci. Off. J. Soc. Neurosci. 42, 5102&#x2013;5114 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9233439</ArticleId><ArticleId IdType="pubmed">35606145</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredj N. B., et al. , Depolarization-induced translocation of the RNA-binding protein Sam68 to the dendrites of hippocampal neurons. J. Cell Sci. 117, 1079&#x2013;1090 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14996936</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiruchinapalli D. M., et al. , Activity-dependent trafficking and dynamic localization of zipcode binding protein 1 and &#x3b2;-Actin mRNA in dendrites and spines of hippocampal neurons. J. Neurosci. 23, 3251&#x2013;3261 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742306</ArticleId><ArticleId IdType="pubmed">12716932</ArticleId></ArticleIdList></Reference><Reference><Citation>Antar L. N., Afroz R., Dictenberg J. B., Carroll R. C., Bassell G. J., Metabotropic glutamate receptor activation regulates Fragile X mental retardation protein and Fmr1 mRNA localization differentially in dendrites and at synapses. J. Neurosci. 24, 2648&#x2013;2655 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6729525</ArticleId><ArticleId IdType="pubmed">15028757</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalavadi V. C., et al. , Regulation of zipcode binding protein 1 transport dynamics in axons by myosin Va. J. Neurosci. Off. J. Soc. Neurosci. 32, 15133&#x2013;15141 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3508068</ArticleId><ArticleId IdType="pubmed">23100434</ArticleId></ArticleIdList></Reference><Reference><Citation>Weskamp K., et al. , Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS. J. Clin. Invest. 130, 1139&#x2013;1155 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269575</ArticleId><ArticleId IdType="pubmed">31714900</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano G., et al. , Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA-induced neuronal death. J. Neurochem. 94, 808&#x2013;818 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16000164</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia C. A., Ju W., Liu R., Matrin 3 is a Ca2+/calmodulin-binding protein cleaved by caspases. Biochem. Biophys. Res. Commun. 361, 281&#x2013;286 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17658460</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X., et al. , Scanning the human proteome for calmodulin-binding proteins. Proc. Natl. Acad. Sci. U.S.A. 102, 5969&#x2013;5974 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1087907</ArticleId><ArticleId IdType="pubmed">15840729</ArticleId></ArticleIdList></Reference><Reference><Citation>Deisseroth K., Heist E. K., Tsien R. W., Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 392, 198&#x2013;202 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9515967</ArticleId></ArticleIdList></Reference><Reference><Citation>Mermelstein P. G., Deisseroth K., Dasgupta N., Isaksen A. L., Tsien R. W., Calmodulin priming: Nuclear translocation of a calmodulin complex and the memory of prior neuronal activity. Proc. Natl. Acad. Sci. U.S.A. 98, 15342&#x2013;15347 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC65031</ArticleId><ArticleId IdType="pubmed">11742070</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H., et al. , &#x3b3;CaMKII shuttles Ca2+/CaM to the nucleus to trigger CREB phosphorylation and gene expression. Cell 159, 281&#x2013;294 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201038</ArticleId><ArticleId IdType="pubmed">25303525</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S. M., et al. , Excitation-transcription coupling in parvalbumin-positive interneurons employs a novel CaM kinase-dependent pathway distinct from excitatory neurons. Neuron 90, 292&#x2013;307 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4866871</ArticleId><ArticleId IdType="pubmed">27041500</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S. M., et al. , Calmodulin shuttling mediates cytonuclear signaling to trigger experience-dependent transcription and memory. Nat. Commun. 9, 2451 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015085</ArticleId><ArticleId IdType="pubmed">29934532</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayaprolu S., et al. , Heterogeneity of Matrin 3 in the developing and aging murine central nervous system. J. Comp. Neurol. 524, 2740&#x2013;2752 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5832027</ArticleId><ArticleId IdType="pubmed">26878116</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C., Fass D. M., Reynolds I. J., Emergence of excitotoxicity in cultured forebrain neurons coincides with larger glutamate-stimulated [Ca2+]i increases and NMDA receptor mRNA levels. Brain Res. 849, 97&#x2013;108 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10592291</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik A. M., et al. , Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization. Elife 7, e35977 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6050042</ArticleId><ArticleId IdType="pubmed">30015619</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores B. N., et al. , An intramolecular salt bridge linking TDP43 RNA binding, protein stability, and TDP43-dependent neurodegeneration. Cell Rep. 27, 1133&#x2013;1150.e8 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499398</ArticleId><ArticleId IdType="pubmed">31018129</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold H. C., et al. , TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci Rep-uk 8, 4606 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Weskamp K., Safren N., Miguez R., Barmada S., Monitoring neuronal survival via longitudinal fluorescence microscopy. J. Vis. Exp. 143 (2019), 10.3791/59036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/59036</ArticleId><ArticleId IdType="pmc">PMC6594158</ArticleId><ArticleId IdType="pubmed">30735193</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrasate M., Finkbeiner S., Automated microscope system for determining factors that predict neuronal fate. Proc. Natl. Acad. Sci. U.S.A. 102, 3840&#x2013;3845 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC553329</ArticleId><ArticleId IdType="pubmed">15738408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao C. S., et al. , Selective neuronal degeneration in MATR3 S85C knock-in mouse model of early-stage ALS. Nat. Commun. 11, 5304 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7576598</ArticleId><ArticleId IdType="pubmed">33082323</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsubuki S., Saito Y., Tomioka M., Ito H., Kawashima S., Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J. Biochem. 119, 572&#x2013;576 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8830056</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto A., et al. , Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in Rat Hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 23, 33&#x2013;42 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9639028</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonvini P., Zorzi E., Basso G., Rosolen A., Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma. Leukemia 21, 838&#x2013;842 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17268529</ArticleId></ArticleIdList></Reference><Reference><Citation>Marco G. D., et al. , Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis. Sci. Rep.-uk 12, 395 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8748718</ArticleId><ArticleId IdType="pubmed">35013445</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi S., et al. , Calpain-mediated X-linked Inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia*. J. Biol. Chem. 277, 33968&#x2013;33977 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12121983</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Boor P. J., Finnerty C. C., Herndon D. N., Albrecht T., Calpain-mediated cleavage of p53 in human cytomegalovirus-infected lung fibroblasts. Faseb Bioadv. 1, 151&#x2013;166 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6996331</ArticleId><ArticleId IdType="pubmed">32123827</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamakubo T., Kannagi R., Murachi T., Matus A., Distribution of calpains I and II in rat brain. J. Neurosci. 6, 3103&#x2013;3111 (1986).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6568489</ArticleId><ArticleId IdType="pubmed">3021924</ArticleId></ArticleIdList></Reference><Reference><Citation>Akashiba H., Matsuki N., Nishiyama N., Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons. J. Neurochem. 99, 733&#x2013;744 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16824045</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhang Y., Regulation of TET Protein Stability by Calpains. Cell Rep. 6, 278&#x2013;284 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4227594</ArticleId><ArticleId IdType="pubmed">24412366</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Li Q., Youn J. Y., Cai H., Protein phosphotyrosine phosphatase 1B (PTP1B) in calpain-dependent feedback regulation of vascular endothelial growth factor receptor (VEGFR2) in Endothelial Cells IMPLICATIONS IN VEGF-DEPENDENT ANGIOGENESIS AND DIABETIC WOUND HEALING*. J. Biol. Chem. 292, 407&#x2013;416 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5241720</ArticleId><ArticleId IdType="pubmed">27872190</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.-X., et al. , Precise prediction of calpain cleavage sites and their aberrance caused by mutations in cancer. Front. Genet. 10, 715 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6694742</ArticleId><ArticleId IdType="pubmed">31440276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N., Kour S., Anderson E. N., Rajasundaram D., Pandey U. B., RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM. Acta Neuropathol. Commun. 8, 138 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437177</ArticleId><ArticleId IdType="pubmed">32811564</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap K. L., et al. , Calmodulin target database. J. Struct. Funct. Genom. 1, 8&#x2013;14 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">12836676</ArticleId></ArticleIdList></Reference><Reference><Citation>Mruk K., Farley B. M., Ritacco A. W., Kobertz W. R., Calmodulation meta-analysis: Predicting calmodulin binding via canonical motif clustering. J. Gen. Physiol. 144, 105&#x2013;114 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4076516</ArticleId><ArticleId IdType="pubmed">24935744</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi W. A., Asif A., Andleeb S., Ul Amir Afsar Minhas F., CaMELS: In silico prediction of calmodulin binding proteins and their binding sites. Proteins Struct. Funct. Bioinform. 85, 1724&#x2013;1740 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28598584</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura Y., et al. , Matrin3 binds directly to intronic pyrimidine-rich sequences and controls alternative splicing. Genes Cells 22, 785&#x2013;798 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28695676</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson R. B., Kemp B. E., Protein kinase phosphorylation site sequences and consensus specificity motifs: Tabulations. Methods Enzymol. 200, 62&#x2013;81 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1956339</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglass J., et al. , Identifying protein kinase target preferences using mass spectrometry. Am. J. Physiol. Cell Physiol. 303, C715&#x2013;27 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3774550</ArticleId><ArticleId IdType="pubmed">22723110</ArticleId></ArticleIdList></Reference><Reference><Citation>Vorherr T., et al. , The calmodulin binding domain of nitric oxide synthase and adenylyl cyclase. Biochemistry-us 32, 6081&#x2013;6088 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">7685187</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu C., Cooper D. M. F., Calmodulin-binding sites on adenylyl cyclase Type VIII*. J. Biol. Chem. 274, 8012&#x2013;8021 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10075700</ArticleId></ArticleIdList></Reference><Reference><Citation>Masada N., Ciruela A., MacDougall D. A., Cooper D. M. F., Distinct mechanisms of regulation by Ca2+/calmodulin of Type 1 and 8 Adenylyl Cyclases support their different physiological roles*. J.&#xa0;Biol. Chem. 284, 4451&#x2013;4463 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2640985</ArticleId><ArticleId IdType="pubmed">19029295</ArticleId></ArticleIdList></Reference><Reference><Citation>Skeberdis V. A., et al. , Protein kinase A regulates calcium permeability of NMDA receptors. Nat. Neurosci. 9, 501&#x2013;510 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16531999</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy J. A., et al. , Phosphorylation of Ser1166 on GluN2B by PKA is critical to synaptic NMDA receptor function and Ca2+ signaling in spines. J. Neurosci. 34, 869&#x2013;879 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3891964</ArticleId><ArticleId IdType="pubmed">24431445</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T., Sato A., Kitsukawa T., Sasaoka T., Yamamori T., Expression pattern of immediate early genes in the cerebellum of D1R KO, D2R KO, and wild type mice under vestibular-controlled activity. Front. Cell Dev. Biol. 3, 38 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4469897</ArticleId><ArticleId IdType="pubmed">26137459</ArticleId></ArticleIdList></Reference><Reference><Citation>Kn&#xf6;ferle J., et al. , Mechanisms of acute axonal degeneration in the optic nerve in&#xa0;vivo. Proc. Natl. Acad. Sci. U.S.A. 107, 6064&#x2013;6069 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2851885</ArticleId><ArticleId IdType="pubmed">20231460</ArticleId></ArticleIdList></Reference><Reference><Citation>Vingtdeux V., et al. , AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J. Biol. Chem. 285, 9100&#x2013;9113 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2838330</ArticleId><ArticleId IdType="pubmed">20080969</ArticleId></ArticleIdList></Reference><Reference><Citation>Djakovic S. N., Schwarz L. A., Barylko B., DeMartino G. N., Patrick G. N., Regulation of the proteasome by neuronal activity and calcium/calmodulin-dependent protein kinase ii*. J. Biol. Chem. 284, 26655&#x2013;26665 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2785353</ArticleId><ArticleId IdType="pubmed">19638347</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J. Y., Jang S. Y., Shin Y. K., Suh D. J., Park H. T., Calcium-dependent proteasome activation is required for axonal neurofilament degradation. Neural. Regen. Res. 8, 3401&#x2013;3409 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4146008</ArticleId><ArticleId IdType="pubmed">25206662</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes J. L., Strayer M. S., Matera A. G., Molecular determinants of survival motor neuron (SMN) protein cleavage by the calcium-activated protease, calpain. Plos One 5, e15769 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3012718</ArticleId><ArticleId IdType="pubmed">21209906</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T., et al. , A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat. Commun. 3, 1307 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23250437</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T., Teramoto S., Kwak S., Phosphorylated TDP-43 becomes resistant to cleavage by calpain: A regulatory role for phosphorylation in TDP-43 pathology of ALS/FTLD. Neurosci. Res. 107, 63&#x2013;69 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26723245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornbeck P. V., et al. , PhosphoSitePlus, 2014: Mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512&#x2013;D520 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383998</ArticleId><ArticleId IdType="pubmed">25514926</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao M. V., Campbell J., Palaniappan A., Kumar A., Nixon R. A., Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice. J. Neurochem. 137, 253&#x2013;265 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828294</ArticleId><ArticleId IdType="pubmed">26756888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zech M., et al. , MATR3 haploinsufficiency and early-onset neurodegeneration. Brain 144, e72&#x2013;e72 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34173818</ArticleId></ArticleIdList></Reference><Reference><Citation>Tischbein M., et al. , The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for GRIA2 mRNA processing. J. Biol. Chem. 294, 10194&#x2013;10210 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664169</ArticleId><ArticleId IdType="pubmed">31092554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kan M.-C., et al. , CPEB4 is a cell survival protein retained in the nucleus upon ischemia or endoplasmic reticulum calcium depletion. Mol. Cell Biol. 30, 5658&#x2013;5671 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3004280</ArticleId><ArticleId IdType="pubmed">20937770</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J. H., et al. , Cytosolic calcium regulates cytoplasmic accumulation of TDP-43 through Calpain-A and Importin &#x3b1;3. Elife 9, e60132 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7748415</ArticleId><ArticleId IdType="pubmed">33305734</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T., Aizawa H., Teramoto S., Akamatsu M., Kwak S., Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons. Sci. Rep.uk 7, 39994 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5206745</ArticleId><ArticleId IdType="pubmed">28045133</ArticleId></ArticleIdList></Reference><Reference><Citation>Delane K. J., et al. , Calmodulin interacts with and regulates the RNA-binding activity of an Arabidopsis polyadenylation factor subunit. Plant Physiol. 140, 1507&#x2013;1521 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1459842</ArticleId><ArticleId IdType="pubmed">16500995</ArticleId></ArticleIdList></Reference><Reference><Citation>Saladino P., et al. , RNA-binding activity of the rat calmodulin-binding PEP-19 protein and of the long PEP-19 isoform. Int. J. Mol. Med. 29, 141&#x2013;145 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22020791</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell J. C., et al. , FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247&#x2013;261 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3232425</ArticleId><ArticleId IdType="pubmed">21784246</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki Y., et al. , Phosphorylation of zipcode binding protein 1 is required for brain-derived neurotrophic factor signaling of local -actin synthesis and growth cone turning. J. Neurosci. 30, 9349&#x2013;9358 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2908896</ArticleId><ArticleId IdType="pubmed">20631164</ArticleId></ArticleIdList></Reference><Reference><Citation>Feit H., et al. , Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: Clinical description and gene localization to 5q31. Am. J. Hum. Genet. 63, 1732&#x2013;1742 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1377645</ArticleId><ArticleId IdType="pubmed">9837826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraya T., Schmidt B., M&#xfc;LLER T., Hanisch F., Impairment of respiratory function in late-onset distal myopathy due to MATR3 Mutation. Muscle Nerve 51, 916&#x2013;918 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25677933</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmio J., et al. , Re-evaluation of the phenotype caused by the common MATR3 p.Ser85Cys mutation in a new family. J. Neurol. Neurosurg. Psychiatry 87, 448 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">25952333</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., et al. , Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in Drosophila. Febs Lett. 594, 2800&#x2013;2818 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32515490</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp C. M., Oliver W. T., Wheeler T. L., Chishti A. H., Koohmaraie M., The effects of Capn1 gene inactivation on skeletal muscle growth, development, and atrophy, and the compensatory role of other proteolytic systems. J. Anim. Sci. 91, 3155&#x2013;3167 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3962768</ArticleId><ArticleId IdType="pubmed">23798514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince P., et al. , Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropath. Appl. Neuro. 19, 291&#x2013;299 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8232749</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexianu M. E., et al. , The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 36, 846&#x2013;858 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7998770</ArticleId></ArticleIdList></Reference><Reference><Citation>Saudou F., Finkbeiner S., Devys D., Greenberg M. E., Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55&#x2013;66 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9778247</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelstein A., Amodaj N., Hoover K., Vale R., Stuurman N., Computer control of microscopes using &#xb5;Manager. Curr. Protoc. Mol. Biol. 92, 14.20.1&#x2013;14.20.17 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3065365</ArticleId><ArticleId IdType="pubmed">20890901</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercer A. A., Palarz K. J., Tabatadze N., Woolley C. S., Raman I. M., Sex differences in cerebellar synaptic transmission and sex-specific responses to autism-linked Gabrb3 mutations in mice. Elife 5, e07596 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878876</ArticleId><ArticleId IdType="pubmed">27077953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ankri L., Yarom Y., Uusisaari M. Y., Slice it hot: Acute adult brain slicing in physiological temperature. J. Vis. Exp. Jove. 92, e52068 (2014), 10.3791/52068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/52068</ArticleId><ArticleId IdType="pmc">PMC4353380</ArticleId><ArticleId IdType="pubmed">25406663</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz M. L., et al. , Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann-Pick diseases. Bmc Med. 17, 200 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6849328</ArticleId><ArticleId IdType="pubmed">31711490</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>